Compare OSPN & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OSPN | OVID |
|---|---|---|
| Founded | 1991 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 500.5M | 522.6M |
| IPO Year | 2000 | 2017 |
| Metric | OSPN | OVID |
|---|---|---|
| Price | $13.32 | $2.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $16.67 | $4.60 |
| AVG Volume (30 Days) | 514.9K | ★ 2.2M |
| Earning Date | 04-30-2026 | 05-13-2026 |
| Dividend Yield | ★ 4.53% | N/A |
| EPS Growth | ★ 28.77 | 3.90 |
| EPS | ★ 0.30 | N/A |
| Revenue | ★ $243,180,000.00 | $7,252,000.00 |
| Revenue This Year | $3.22 | N/A |
| Revenue Next Year | $3.16 | $19.34 |
| P/E Ratio | $45.00 | ★ N/A |
| Revenue Growth | N/A | ★ 1181.27 |
| 52 Week Low | $10.07 | $0.30 |
| 52 Week High | $18.13 | $3.11 |
| Indicator | OSPN | OVID |
|---|---|---|
| Relative Strength Index (RSI) | 43.85 | 41.34 |
| Support Level | $12.09 | $2.16 |
| Resistance Level | $13.38 | $2.38 |
| Average True Range (ATR) | 0.57 | 0.16 |
| MACD | -0.21 | -0.01 |
| Stochastic Oscillator | 6.75 | 19.01 |
OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. The company build secure, seamless, and trusted digital experiences through two solution portfolios: Cybersecurity solutions engaged in protecting identities, securing mobile apps, and safeguarding access through high-assurance authentication, threat intelligence, fraud prevention, and robust mobile app protection, defending users, devices, and applications against sophisticated attacks, while Digital agreement solutions focuses on streamlining workflows with secure e-signatures, identity verification, and smart digital forms, built to enable speed, compliance and other customer experiences.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.